Nanotechnology Characterization Laboratory (NCL)
|
Research Initiative
|
FDA
|
|
2004
|
|
NAPA Federal Subgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, ACL, CDC, CMS, FDA, HRSA, IHS
|
NINDS
|
2014
|
|
NASEM Aging Disability and Independence Forum
|
Committee, Advisory Group, or Work Group
|
ACL
|
|
2014
|
|
NASEM Forum on Drug Discovery, Development, and Translation
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NINDS, NIAID, NCI, NIMH, OD/ OSP, NCATS
|
|
|
NASEM Forum on Neuroscience and Nervous System Disorders
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIMH, NIAAA, NIA, NIEHS, NIDA
|
2006
|
|
NASEM Forum on Traumatic Brain Injury
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD, NIA
|
2022
|
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAAA, NIDA, OD/ DPCPSI/ OBSSR
|
2010
|
|
National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Action Plan for the Elimination of multi-drug resistant Tuberculosis (MDR TB)
|
Other
|
CDC
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA
|
2015
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Advisory Committee on Children and Disasters (NAACD)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, ASPR
|
NICHD, NIEHS
|
|
|
National Amyotrophic Lateral Sclerosis Registry (National ALS Registry)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Asthma Education and Prevention Program
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
1989
|
|
National Biodefense Strategy - Vaccines Joint Capabilities Plan writing group
|
Other
|
ASPR, CDC, FDA
|
NIAID
|
2022
|
|
National Cancer Control Strategy
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2017
|
|
National Center for Advancing Translational Sciences (NCATS) Toolkit for Patient-focused Therapy Development
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2008
|
|
National Coalition for Oversight of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NICHD, NHLBI, NIDDK, FIC, NIAMS, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ONR, OD/ ECHO
|
2010
|
|
National Counterintelligence Task Force (NCITF)
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
2019
|
|
National COVID Cohort Collaborative (N3C)
|
Research Initiative
|
FDA, ASPR, CMS
|
NCATS, NIGMS
|
2021
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Death Index Linkage Collaboration (NIH-NDI Agreement)
|
Resource Development
|
CDC
|
OD/ DPCPSI/ OBSSR, OD/ IMOD
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2018
|
|
|